Detalhe da pesquisa
1.
Signals of pseudo-starvation unveil the amino acid transporter SLC7A11 as key determinant in the control of Treg cell proliferative potential.
Immunity
; 54(7): 1543-1560.e6, 2021 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34004141
2.
Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants.
Nat Immunol
; 16(11): 1174-84, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26414764
3.
Comparing Natural History of Early and Late Onset Pediatric Multiple Sclerosis.
Ann Neurol
; 91(4): 483-495, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35150168
4.
A score that predicts aquaporin-4 IgG positivity in patients with longitudinally extensive transverse myelitis.
Eur J Neurol
; 30(8): 2534-2538, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37170839
5.
Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study.
Brain
; 145(8): 2796-2805, 2022 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325059
6.
Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals' perspective.
Neurol Sci
; 44(1): 45-58, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36114980
7.
Epigenetics: An opportunity to shape innate and adaptive immune responses.
Immunology
; 167(4): 451-470, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36043705
8.
Switch from sequestering to anti-CD20 depleting treatment: disease activity outcomes during wash-out and in the first 6 months of ocrelizumab therapy.
Mult Scler
; 28(1): 93-101, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33855897
9.
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register.
Mult Scler
; 28(14): 2243-2252, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35971322
10.
A real-world study of alemtuzumab in a cohort of Italian patients.
Eur J Neurol
; 29(1): 257-266, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34558755
11.
Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors.
Mult Scler
; 27(3): 430-438, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33210986
12.
Reduced Annexin A1 Expression Associates with Disease Severity and Inflammation in Multiple Sclerosis Patients.
J Immunol
; 203(7): 1753-1765, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31462505
13.
GAD65 autoimmunity after treatment with nivolumab: a multifocal presentation.
Neurol Sci
; 42(10): 4289-4291, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33977307
14.
Anti-MOG-associated demyelinating disorders: two sides of the same coin.
Neurol Sci
; 42(4): 1531-1534, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33190197
15.
Epileptic seizures of suspected autoimmune origin: a multicentre retrospective study.
J Neurol Neurosurg Psychiatry
; 91(11): 1145-1153, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32859745
16.
Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study.
J Neurol Neurosurg Psychiatry
; 91(9): 914-920, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32661083
17.
Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study.
Neurol Sci
; 41(10): 2905-2913, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32335779
18.
THC/CBD oromucosal spray in patients with multiple sclerosis overactive bladder: a pilot prospective study.
Neurol Sci
; 39(1): 97-102, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29052091
19.
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 93(4): 448-450, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34408003
20.
Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression.
Mult Scler
; 22(5): 659-67, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26362896